CYP1A2 genotype and rheumatoid arthritis in Koreans

Rheumatology International

Volumn 30, Issue 10, 2010, Pages 1349-1354

  Cornelis, Marilyn C ^a   Bae, Sang Cheol ^b   Kim, Il ^b   El Sohemy, Ahmed ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Hanyang University Hospital for Rheumatic Diseases   (South Korea)

Author keywords

Case control; CYP1A2; Genotype; Rheumatoid arthritis

Indexed keywords

(1 BUTYLAMINO 3 METHYLBUTYL)(1 PYRROLIDINYL) KETONE; CYTOCHROME P450 1A2; DNA; EPITOPE; HLA DR ANTIGEN; REACTIVE OXYGEN METABOLITE; CYP1A2 PROTEIN, HUMAN; HLA DRB1 ANTIGEN;

ADULT; ALLELE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; CASE CONTROL STUDY; CASE REPORT; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; RISK; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; KOREA; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; HLA-DRB1 CHAINS;

EID: 77955557762     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1050-0     Document Type: Article

References (47)

1. GS Firestein F Echeverri M Yeo NJ Zvaifler DR Green 1997 Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium Proc Natl Acad Sci 94 10895 10900 10.1073/pnas.94.20.10895 1:CAS:528: DyaK2sXmtlCgt7s%3D 9380731 (Pubitemid 27430832)
2. WP Arand 2001 The innate immune system in rheumatoid arthritis Arthritis Rheum 44 2224 2234 10.1002/1529-0131(200110)44:10<2224::AID-ART384>3.0. CO;2-H (Pubitemid 32977489)
3. AJ MacGregor H Snieder AS Rigby M Koskenvuo J Kaprio K Aho AJ Silman 2000 Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins Arthritis Rheum 43 30 37 10.1002/1529-0131(200001)43: 1<30::AID-ANR5>3.0.CO;2-B 1:STN:280:DC%2BD3c7gs1Cqsw%3D%3D 10643697 (Pubitemid 30368210)
4. BP Wordsworth J Bell 1991 Polygenic susceptibility in rheumatoid arthritis Ann Rheum Dis 50 343 346 10.1136/ard.50.6.343 1:STN:280: DyaK3M3ot1GnsA%3D%3D 2059076
5. I Moreno A Valenzuela A Garcia J Yelamos B Sanchez W Hernanz 1996 Association of the shared epitope with radiological severity of rheumatoid arthritis J Rheumatol 23 6 9 1:STN:280:DyaK28vjsFKitw%3D%3D 8838501
6. JD Gorman RF Lum JJ Chen ME Suarez-Almazor G Thomson LA Criswell 2004 Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3, 240 rheumatoid arthritis patients Arthritis Rheum 50 400 412 10.1002/art.20006 14872482 (Pubitemid 38198824)
7. C Deighton DJ Walker ID Griffiths DF Roberts 1989 The contribution of HLA to rheumatoid arthritis Clin Genet 36 178 182 10.1111/j.1399-0004.1989.tb03185. x 1:STN:280:DyaK3c%2Fgtlymtg%3D%3D 2676268
8. B Halliwell 1995 Oxygen radicals, nitric oxide and human inflammatory joint disease Ann Rheum Dis 54 505 510 10.1136/ard.54.6.505 1:STN:280: DyaK2MzlvVKnsw%3D%3D 7632097
9. MM Maurice H Nakamura E van der Voort AI van Vliet FJ Staal PP Tak FC Breedveld CL Verweij 1997 Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis J Immunol 158 1458 1463 1:CAS:528:DyaK2sXitFahs7g%3D 9013992
10. VR Winrow PG Winyard CJ Morris DR Blake 1993 Free radicals in inflammation: second messengers and mediators of tissue destruction Br Med Bull 49 506 522 1:CAS:528:DyaK2cXltFagtg%3D%3D 8221019
11. J Ara R Ali 1992 Reactive oxygen species modified DNA fragments of varying size are the preferred antigen for human anti-DNA autoantibodies Immunol Lett 34 195 200 10.1016/0165-2478(92)90213-8 1:CAS:528:DyaK3sXhsVGmtrc%3D 1283155 (Pubitemid 23005782)
12. BR Yun A El-Sohemy MC Cornelis SC Bae 2005 Glutathione S-transferase M1, T1, and P1 genotypes and rheumatoid arthritis J Rheumatol 32 992 997 1:CAS:528:DC%2BD2MXmtValtb4%3D 15940757
13. DL Mattey AB Hassell PT Dawes PW Jones L Yengi J Alldersea RC Strange AA Fryer 2000 Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes Arthritis Rheum 43 859 864 10.1002/1529- 0131(200004)43:4<859::AID-ANR17>3.0.CO;2-Y 1:CAS:528:DC%2BD3cXivFOitrc%3D 10765931
14. B Testa SD Kramer 2007 The biochemistry of drug metabolism-an introduction: Part 2. Redox reactions and their enzymes Chem Biodivers 4 257 405 10.1002/cbdv.200790032 1:CAS:528:DC%2BD2sXjvFCnur0%3D 17372942 (Pubitemid 46937873)
15. S Puntarulo AI Cederbaum 1998 Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes Free Radic Biol Med 24 1324 1330 10.1016/S0891-5849(97)00463-2 1:CAS:528:DyaK1cXjsFWht7Y%3D 9626590 (Pubitemid 28246749)
16. C Beyeler AK Daly M Armstrong C Astbury HA Bird JR Idle 1994 Phenotype/genotype relationships for the cytochrome P450 CYP2D6 in rheumatoid arthritis: influence of drug therapy and disease activity J Rheumatol 21 1034 1039 1:STN:280:DyaK2M%2FhslyqsQ%3D%3D 7932410
17. JH Yen CJ Chen WC Tsai CH Lin TT Ou CJ Hu HW Liu 2003 Manganese superoxide dismutase and cytochrome P450 1A1 genes polymorphisms in rheumatoid arthritis in Taiwan Hum Immunol 64 366 373 10.1016/S0198-8859(02)00818-2 1:CAS:528:DC%2BD3sXht1Kgu7g%3D 12590982 (Pubitemid 36255277)
18. T Shimada H Yamazaki M Mimura Y Inui FP Guengerich 1994 Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians J Pharmacol Exp Ther 270 414 423 1:CAS:528: DyaK2cXlt1OmtL4%3D 8035341
19. D Sesardic AR Boobis RJ Edwards DS Davies 1988 A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking Br J Clin Pharmacol 26 363 372 1:CAS:528:DyaL1MXhvFOgsw%3D%3D 3190986
20. DR Abernethy EL Todd 1985 Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives Eur J Clin Pharmacol 28 425 428 10.1007/BF00544361 1:CAS:528:DyaL2MXkvVWht78%3D 4029248 (Pubitemid 15063812)
21. W Kalow KB Tang 1991 Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking Clin Pharmacol Ther 49 44 48 1:CAS:528:DyaK3MXktVejsLw%3D 1988240
22. L Le Marchand AA Franke L Custer LR Wilkens RV Cooney 1997 Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol Pharmacogenetics 7 11 19 10.1097/00008571- 199702000-00002 1:STN:280:DyaK2s3msVGgsw%3D%3D 9110357 (Pubitemid 27153315)
23. N Rizzo E Hispard S Dolbeault S Dally R Leverge C Girre 1997 Impact of long-term ethanol consumption on CYP1A2 activity Clin Pharmacol Ther 62 505 509 10.1016/S0009-9236(97)90045-X 1:CAS:528:DyaK2sXnvVGrtr8%3D 9390106 (Pubitemid 28214927)
24. JW Lampe IB King S Li MT Grate KV Barale C Chen Z Feng JD Potter 2000 Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets Carcinogenesis 21 1157 1162 10.1093/carcin/21.6.1157 1:CAS:528:DC%2BD3cXksF2gs7w%3D 10837004
25. CA Miller LB Slusher ES Vesell 1985 Polymorphism of theophylline metabolism in man J Clin Invest 75 1415 1425 10.1172/JCI111843 1:CAS:528:DyaL2MXktFKgtLY%3D 4039734
26. BB Rasmussen TH Brix K Kyvik K Brosen 2002 The interindividual differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors Pharmacogenetics 12 473 478 10.1097/00008571-200208000-00008 1:CAS:528:DC%2BD38XmslejtLk%3D 12172216 (Pubitemid 34913530)
27. F Castorena-Torres A Mendoza-Cantu MB de Leon B Cisneros O Zapata-Perez L Lopez-Carrillo JE Salinas A Albores 2005 CYP1A2 phenotype and genotype in a population from Carboniferous Region of Coahuila, Mexico Toxicol Lett 156 331 339 10.1016/j.toxlet.2004.12.005 1:CAS:528:DC%2BD2MXitFeqtbs%3D 15763632 (Pubitemid 40342566)
28. X Han D Ou-Yang P Lu C Jiang Y Shu X Chen Z Tan H Zhou 2001 Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734 polymorphisms of human CYP1A2 Pharmacogenetics 11 429 435 10.1097/00008571- 200107000-00006 1:CAS:528:DC%2BD3MXlvVynsbc%3D 11470995 (Pubitemid 32656583)
29. C Sachse J Brockmoller S Bauer I Roots 1999 Functional significance of a C to A polymorphism in intron 1 of the cytochrome P450 1A2 (CYP1A2) gene tested with caffeine Br J Clin Pharmacol 47 445 449 10.1046/j.1365-2125.1999.00898.x 1:CAS:528:DyaK1MXivVCmtLo%3D 10233211 (Pubitemid 29161279)
30. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper LA Healey SR Kaplan MH Liang HS Luthra, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 3358796
31. S-C Bae EF Cook SY Kim 1998 Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research J Rheumatol 25 1975 1979 1:STN:280:DyaK1cvltFWgsQ%3D%3D 9779853
32. O Steinbrocker CH Traeger RC Batterman 1949 Therapeutic criteria in rheumatoid arthritis JAMA 140 659 662 1:STN:280:DyaH1M%2FltFyltw%3D%3D
33. CE Jones RJ Rousseau KW Maxwell 1979 Quantitation of rheumatoid factor activity by nephelometry Am J Clin Pathol 72 432 436 1:CAS:528: DyaL3cXks1ygsLs%3D 474525
34. MC Cornelis A El-Sohemy H Campos 2004 Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction J Med Genet 41 758 762 10.1136/jmg.2004.022012 1:CAS:528:DC%2BD2cXpsl2gsbc%3D 15466009 (Pubitemid 39389292)
35. Bignon JD, Fernandez-Vina MA (1997) Protocols of the 12th International Histocompatibility Workshop for typing of HLA class II alleles by DNA amplification by the polymerase chain reaction (PCR) and hybridization with sequence specific oligonucleotide probes (SSOP). In: Charron D (ed) Genetic diversity of HLA: Functional and medical implication. EDK, Paris, pp 584-595
36. K Kotsch J Wehling R Blasczyk 1999 Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: sequencing based typing of HLA-DRB genes Tissue Antigens 53 486 497 10.1034/j.1399-0039.1999.530505.x 1:CAS:528:DyaK1MXjslCmur8%3D 10372544 (Pubitemid 29224487)
37. M Heliovaara K Aho A Aromaa P Knekt A Reunanen 1993 Smoking and risk of rheumatoid arthritis J Rheumatol 20 1830 1835 1:STN:280:DyaK2c7ktFOrsw%3D%3D 8308766
38. L Padyukov C Silva P Stolt L Alfredsson L Klareskog 2004 A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis Arthritis Rheum 50 3085 3092 10.1002/art.20553 1:CAS:528:DC%2BD2cXpvFaisbw%3D 15476204 (Pubitemid 39371983)
39. L Klareskog P Stolt K Lundberg H Kallberg C Bengtsson J Grunewald J Ronnelid HE Harris AK Ulfgren S Rantapaa-Dahlqvist A Eklund L Padyukov L Alfredsson 2006 A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination Arthritis Rheum 54 38 46 10.1002/art.21575 1:CAS:528:DC%2BD28XhsVens78%3D 16385494 (Pubitemid 43122184)
40. C Kyogoku N Tsuchiya K Matsuta K Tokunaga 2002 Studies on the association of Fcgamma receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A Genes Immun 3 488 493 10.1038/sj.gene.6363921 1:CAS:528: DC%2BD38XpsFWgtbc%3D 12486608 (Pubitemid 41656533)
41. H Wu D Khanna G Park V Gersuk GT Nepom WK Wong HE Paulus BP Tsao 2004 Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort Arthritis Rheum 50 3093 3103 10.1002/art.20555 1:CAS:528:DC%2BD2cXpvFaisb0%3D 15476205 (Pubitemid 39371984)
42. S Ling Z Li O Borschukova L Xiao P Pumpens J Holoshitz 2007 The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway Arthritis Res Ther 9 R5 10.1186/ar2111 17254342 (Pubitemid 46322631)
43. L Gu FJ Gonzalez W Kalow BK Tang 1992 Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1 Pharmacogenetics 2 73 77 10.1097/00008571-199204000-00004 1:CAS:528:DyaK3sXlsFWlsr8%3D 1302044
44. H Yamazaki PM Shaw FP Guengerich T Shimada 1998 Roles of cytochrome P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes Chem Res Toxicol 11 659 665 10.1021/tx970217f 1:CAS:528:DyaK1cXjvFars7c%3D 9625734 (Pubitemid 28285591)
45. M Heliovaara K Aho P Knekt O Impivaara A Reunanen A Aromaa 2000 Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis Ann Rheum Dis 59 631 635 10.1136/ard.59.8.631 1:STN:280:DC%2BD3cvjt1alsw%3D%3D 10913061 (Pubitemid 30617089)
46. MP Vessey L Villard-Mackintosh D Yeates 1987 Oral contraceptives, cigarette smoking and other factors in relation to arthritis Contraception 35 457 464 10.1016/0010-7824(87)90082-5 1:STN:280:DyaL2szgtlSmtg%3D%3D 3621942 (Pubitemid 17139027)
47. R Ghotbi M Christensen HK Roh M Ingelman-Sundberg E Aklillu L Bertilsson 2007 Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans Eur J Clin Pharmacol 63 6 537 546 10.1007/s00228-007-0288-2 1:CAS:528:DC%2BD2sXkslWns70%3D 17370067 (Pubitemid 46684487)